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Abstract
The mammalian gut contains trillions of microbes that interact with host cells and monitor changes
in the environment. Opportunistic pathogens exploit environmental conditions to stimulate their growth
and virulence, leading to a resurgence of chronic disorders such as inflammatory bowel disease (IBD).
Current therapies are effective in less than 30% of patients due to the lack of adherence to prescription
schedules and overall, off-target effects. Smart microbial therapeutics can be engineered to colonize the
gut, providing in situ surveillance and conditional disease modulation. However, many current engineered
microbes can only respond to single gut environmental factors, limiting their effectiveness. In this work,
we implement the previously characterized split activator AND logic gate in the probiotic E. coli strain
Nissle 1917. Our system can respond to two input signals: the inflammatory biomarker tetrathionate
and a second input signal, IPTG. We report 4-6 fold induction with minimal leak when both signals
are present. We model the dynamics of the AND gate using chemical reaction networks, and by tuning
parameters in silico, we identified perturbations that affect our circuit’s selectivity. We anticipate that
our results will prove useful for designing living therapeutics for spatial targeting and signal processing
in complex environments.
1 Introduction
Approximately 1013–1014 bacterial cells live in the dynamic and complex community within the gut
microbiome, where they can impact numerous facets of human health [1–3]. The idea that changes in the
composition of this community result in disease offers a compelling motivation for engineering microbes
to sense, cure, or prevent these perturbations. Engineering microbes for gut diagnostics and therapeutics
is a growing field in synthetic biology, owing to the tractability and relative safety of genome engineering
in microbes. Recent examples include inhibition of pathogenic Pseudomonas aeruginosa via antimicrobial
peptides [4] and delivery of checkpoint blockade nanobodies to tumors [5]. Due to the presence of bacteria
in a wide variety of ecological niches, there exists a wide variety of evolved sensors for therapeutically-
relevant molecules [6]. Microbes’ ability to sense and respond to stimuli in situ offers controlled and targeted
responses to traditionally difficult locations of disease.
One such complex microbiome perturbation is inflammation, which can drive dysbiosis, or disruptions
in microbial populations [7]. Dysbiosis is a root cause of inflammatory bowel disease (IBD) and has been
associated with infectious disease, obesity, and other medical disorders [8]. During IBD, specific niches
within the gut microbiome change, causing spatial heterogeneity [9]. Currently, the most common treatment
method for IBD is large doses of oral anti-inflammatory drugs, which have broad and nonspecific effects
that do not account for the local environmental changes [10]. These anti-inflammatory drugs often require
irregular and frequent dosage schedules challenging to adhere to, with the average patient missing half of
their treatments [11].
Microbes capable of drug manufacture and secretion can colonize the microbiome, providing long-lasting
in situ therapeutics without complex dosing schedules. Recent studies have found promise for inflammation
treatment with microbes secreting interleukin-10 (IL-10) [12], IL-27 [13], and anti-tumor necrosis factor
α [14]. However, these microbes express target molecules constitutively, not taking advantage of the ability
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Figure 1: An example of how AND gates would provide spatial targeting. Production
of the anti-inflammatory drug will only be active if cells detect that they are localized to the gut
epithelium and the inflammation biomarker tetrathionate is present. Thus, anti-inflammatory
action is only performed if the therapeutic cells are in the right place, minimizing off target
effects. Figure not drawn to scale.
of bacteria to sense and respond to their environment. This is especially relevant in IBD, a disease known
to have spatial heterogeneity [7].
Genetic circuits responsive to inflammation are thus of great interest to the field of microbiome engi-
neering. Two inflammatory biomarkers, nitric oxide [15] and tetrathionate [16] have been used as triggers for
memory circuits, allowing for in situ inflammation diagnosis. The second biomarker, tetrathionate, has also
been used to drive expression of microcins capable of inhibiting Salmonella spp. outgrowth [17]. Tetrathion-
ate was first noted as a biomarker of intestinal inflammation by Winter et al. [18]. Salmonella Typhimurium
was found to cause acute gut inflammation, causing the release of reactive oxygen species. These species
react with intestinal sulfur compounds, most notably thiosulfates, causing the formation of a new respiratory
electron acceptor, tetrathionate. S. Typhimurium and other pathogens, like C. jejuni, can gain a growth
advantage by using tetrathionate as an electron acceptor.
Daeffler et al. [6] identified a tetrathionate two-component sensor from the marine bacterium Shewanella
baltica OS195. The system consists of a membrane-bound sensor histidine kinase, ttrS, and a cytoplasmic
response regulator, ttrR. Tetrathionate binds to ttrS, causing phosphorylation, leading to a complex that can
phosphorylate ttrR. Phosphorylated ttrR, in turn, activates pTtr, which demonstrates low cross-activation
by a range of other ligands.
We implemented the hypersensitive response and pathogenicity (hrp) system reported by Wang et
al. [19] to incorporate logical sensing. This system consists of two co-activating genes hrpR and hrpS, which
activate the σ54-dependent hrpL promoter [20]. The genetic elements were isolated from Pseudomonas
syringae and optimized to function with various synthetic biology promoters, including pLac. Because the
circuit is orthogonal to the E. coli genetic background, it can be engineered into E. coli Nissle without host
genome interference. Here, we unite the inflammatory relevance of tetrathionate sensing with the regulatory
control offered by this split activator system.
While microbes have been engineered to respond to environmental factors like inflammation, they are
often limited to sensing single inputs. Here, we develop a logical microbiome response circuit that produces
an output only in the presence of inflammation and an external activator. We build upon the previously char-
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acterized split activator AND logic gate to show selective activation to inflammatory biomarker tetrathionate
and isopropylthiogalactoside (IPTG). We develop a mathematical model of the tetrathionate two-component
system to validate the experimental optimization steps, shown in Section 2.1. Then, in Section 2.2, we de-
scribe experimental results to optimize the two-component system in E. coli Nissle. Building on this further,
we present our main result in Section 2.3. We develop a two plasmid construct that responds selectively
to IPTG and tetrathionate. We conclude our results in Section 2.4 with a discussion on the design space
exploration for the AND gate circuit using a detailed model that describes the effects of leak and points
towards potential improvements in the circuit design. Our work expounds on prior work establishing a new
class of microbial-based therapeutics that processes two inputs to respond in a targeted manner in complex
environments.
Figure 2: Expression and Simulation of Tetrathionate Response Circuit. A.
Schematic of tetrathionate two component system. All shown steps were modeled using chem-
ical reaction networks. B. Relative RBS binding strengths to ttrS and ttrR calculated from
sequenced RBS sites isolated from 4 functioning tetrathionate response circuits. Off rates for
simulated reactions. C. Simulations of RBS tuning by varying ribosome off rates to each ribo-
some binding sites. D. Plate reader time course with increasing tetrathionate concentrations
and different ribosome binding strengths.
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2 Results
2.1 Modeling the Tetrathionate Two-component System
To validate the experimental optimization steps, we use simulations of a mathematical model that
we built by writing the chemical reactions that describe the dynamics of the two-component system. Two
component signaling is one of the most prevalent methods that microbes gene expression from transmembrane
signals [21]. To understand the effects of various experimental tuning steps such as the ribosome binding
strength on the expected output, we describe a model for the tetrathionate signaling system. This model is
divided into three parts — the expression of tetrathionate regulators ttrS and ttrR, phosphorylation of the
tetrathionate regulators, and the reporter gene’s activation.
The regulator’s constitutive expression, ttrS and ttrR are under the common promoter J23103 (P1d) [22].
Since these parts are co-transcribed, we model a single transcription reaction for both regulators. Transcrip-
tion is modeled as a two-step process: binding the promoter to the RNA polymerase to form a complex and
transcription of the complex to the corresponding mRNAs. Since each regulator is under control of its own
ribosome binding site, we have modeled two separate translation reactions. The translation is also modeled
as a two-step process where a ribosome binds to the mRNA transcript to form a complex that then translates
to express the regulator protein.
For the phosphorylation pathway, we model the tetrathionate molecule binding to ttrS as reversibly
triggering phosphorylation. The cytoplasmic response protein ttrR can bind to either the phosphorylated or
dephosphorylated ttrS. If ttrR binds to dephosphorylated ttrS, there is a higher OFF rate than if ttrR binds
to phosphorylated ttrS. Phosphorylation of ttrR only occurs once it binds to the phosphorylated ttrS forming
a complex, ttrR:ttrSP. It is not known whether the dephosphorylation of ttrR is phosphatase dependent,
like the KdpD/KdpE TCS in E. coli [23]. Here, we do not model phosphatase explicitly but rather set an
explicit rate, kdephos, that defines the dephosphorylation of ttrR.
The third and final part of the two-component signaling model is the activation of the GFP reporter
gene. Phosphorylated ttrR may dimerize reversibly within the cytoplasm. It is not known whether inactive
ttrR (that is, dephosphorylated dimers or monomers) can bind to the promoter region. Here, we only model
the dimerized, phosphorylated ttrR as activators of gene expression. Once the activated ttrR binds, the
inactive pTtr promoter is converted to an active state, denoted as pTtr*. RNA polymerase may only bind
to this activated promoter. This triggers the transcription of the GFP transcript, GFPT. This transcript
then binds reversibly with a ribosome and is irreversibly converted into the unbound ribosome, GFPT, and
GFP protein.
Choosing reaction rate parameter values for the different chemical reactions is a critical step in modeling
the signaling system. Since finding exact values for all the rate parameters apriori is impossible, we make a
few simplifying assumptions. We assume that the explicit translation rates are identical for all mRNAs in
the system. Further, we also assume that all degradation reactions occur at the same rate. We selected the
nominal values from the various results and information available in the literature, discussed further in the
supplementary information for all parameters. Since the ribosome binding strength is a tunable parameter in
the experimental design, we keep this parameter free to change during the simulations to observe its effects.
The different RBS strengths are modeled by changing the ribosome’s unbinding reaction rates to a given
transcript.
The model simulations with varying ribosome binding strengths are shown in Figure 2-C. The model
predicts that the RBS preceding the inducers has a strong effect on output fold change. With increasing
ribosome binding strengths, the model simulations show an increased fold change and higher reporter protein
expression. The experimental results seem to show a similar performance with changing RBS strength, as
shown in Figure 2-D. We used a Python toolbox called BioCRNpyler [24] to generate the model and ran
simulations using the Bioscrape [25] simulator. The detailed model including the system’s species, reactions,
and parameters is given in the supplemental information. The Python code used to generate the simulations
shown in Figure 2-C is available publicly on Github [26].
A future line of work would be to quantitatively validate the model parameters by fitting the experi-
mental data to the simulations so that the model can be used to make credible predictions. Since various
parameters in the model are context-dependent, parameter tuning of a validated model in silico may provide
helpful insights when implementing this circuit in the gut environment. Similarly, the effects of resource
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sharing and high burden due to the expression of proteins may be quantified using this model. Towards that
end, we discuss the results from preliminary data collected for the TCS in the next section.
2.2 Tetrathionate sensor validation
The end goal of our construct is implementation into the microbiome. As such, we wanted to minimize
the number of plasmid constructs present in our system. We designed a single construct to have all regulators
as well as the tetrathionate inducible promoter, pTtr, shown in Figure 2-A. We engineered the inducible
promoter after the regulators, which are constitutively expressed. Thus, if the polymerase reads through the
regulator terminator, it would not express the pTtr construct.
Using 3G assembly [27], we constructed a tetrathionate-responsive circuit. To minimize leak while
maximizing circuit response, we screened regulators of varying expression strengths. We optimized the
RBS preceding both tetrathionate sensing regulators ttrS and ttrR using the Andersen RBS pool [22]. We
transformed constructs into JM109 E. coli strain and selected six constructs for sequencing. We estimated
the RBS strengths of the sequenced circuit constructs shown in Figure 3-B [28]. Weak RBS preceding ttrS
or ttrR leads to a lower fold change of GFP expression upon the addition of tetrathionate, as seen in the
simulated results as well. The high activation circuit, LM19, was selected for the next steps due to 13.8x
activation with maximum tetrathionate input.
Figure 3: AND Gate Design and Screening. A. The σ54-dependent promoter hrpL
is activated by two activators: hrpR and hrpS. The expression of hrpR is driven by pTtr, the
tetrathionate response promoter. The second activator, hrpS, is driven by pLac which is induced
by IPTG. Should the AND gate function properly, we expect GFP expression only when both
inducers are present. B. A truth table displaying the expected output. C. The circuit diagram
for co-transformed plasmids. The PSC101 backbone contains KanR, conferring kanamycin
resistance. The ColE1 backbone contains ChlorR, conferring chloramphenicol resistance. D.
Plate screening of AND gate constructs. LB plates contained max inductions of IPTG (1 mM),
Tetrathionate (1 mM), neither, or both. Colonies were streaked on all four plates. Successful
colonies were red fluorescent in all plates, signifying constitutive mScarlet production, and green
fluorescent on the double inducer plate, signifying AND activation. Colonies in the top left two
positions were miniprepped and re-transformed into Nissle.
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2.3 Engineering two-input AND Gate
To incorporate logical sensing, we chose a system of co-dependent split activators to drive expression
of our reporter gene. One regulator, hrpR, is driven by the tetrathionate-dependent promoter. The second
regulator, hrpS, is driven by pLac, which activates in the presence of IPTG. These two regulators form a
homo-hexameric complex needed to activate pHrpL, which drives GFP expression, shown in Figure 3-A.
Our circuit should thus only activate in the presence of tetrathionate and IPTG, shown in the truth table
in Figure 3-B.
While this split activator system has previously been tested in seven different chassis [19], it has not been
tested in E. coli Nissle 1917. We first performed one round of optimization of the AND gate components in
E. coli Marionette Clo cells [29] which natively expresses lacI. Initially, the RBS reported by Wang et al. [19]
were used, with B0034 for hrpR and rbsH for hrpS. However, expression was leaky in all inducer conditions,
suggesting that the activator expression might be too high. To resolve this, we cloned the Anderson library
of ribosome binding sites (ARL) [22] in front of hrpR. We then isolated five constructs with significant fold
change in response to both inducers — IPTG and tetrathionate. Constructs were isolated, sequence verified,
and re-transformed into Nissle, shown in Figure 3-D.
Figure 4: AND Gate Experimental Results. A. Plate reader assay for Nissle AND
constructs. Maximum induction of 1 mM tetrathionate and 1 mM IPTG was used. Fluorescence
values were normalized to OD700 readings. At the experiment’s onset, low OD causes high
normalized values. Maximum induction is achieved by hour 8. B. Heatmap of increasing
inducer concentrations. Values displayed are GFP fluorescence normalized to OD, divided by
the maximal value, which was achieved at 1 mM IPTG and 1 mM tetrathionate. To test the
upper bound of tetrathionate sensing, 10 mM was used, showing slight decrease from the 1 mM
condition. This could be caused by resource loading or cell toxicity at this concentration.
To optimize this system in E. coli Nissle, we found proper expression level of lacI such that pLac can be
regulated. We co-transformed a constitutively expressed lacI and mScarlet plasmid with the working AND
gate plasmid optimized in Marionette Clo. Using stereoscope screening and plate reader assays, we confirmed
the selective AND gate functionality of one dual-plasmid construct, shown in Figure 4-A. In our experimental
results, we observed a 6-fold induction once tetrathionate and IPTG are both added and minimal expression
in the one or no inducer conditions. We further show the AND gate displays digital-like activation across
a range of both inputs Figure 4-B. To the best of our knowledge, this is the first functioning inflammatory
AND gate in E. coli Nissle.
2.4 Design space exploration with an AND gate model
Like the two-component system model, we modeled the AND gate circuit by describing all of the different
mechanisms and components discussed in the previous section. With this model, we explore two key design
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aspects of the system — the effect of RNA polymerase binding selectively with the combinatorial promoter
in the presence of both activator proteins and the effect of initial conditions of the LacI repressors. This
design space exploration points towards further design optimizations possible in the circuit, which would be
essential to harness when implementing this AND gate in the gut microbiome.
Effects of RNAP binding
As shown in Figures 5-A and 5-B, RNA polymerase can bind to the combinatorial promoter, pHrpL,
either when both the activators hrpR and hrpS are present, or when only one of those is bound to the
promoter. Of course, this binding specificity is not experimentally tunable and depends on the designed
constructs and chassis. To study all of these possible interactions and their effects, we model the correspond-
ing reactions in a coarse-grained model. We model the logic gate circuit with a non-zero amount of both
split activator proteins, hrpR and hrpS (R and S, respectively). Using this logic gate model, we performed
preliminary parameter searches to study the combinatorial promoter dynamics.
Due to their high sequence similarity, it may be possible for a single hrp activator (R or S) to gain
the ability to activate transcription, perhaps through mutations in binding domains. To account for this
Figure 5: Parameter Tuning in Protein ANDGate Model. A. Both regulators may bind
to the promoter region, creating a complex capable of being transcribed. RNA polymerase binds
and unbinds with the rates shown. B. A single activator is also able to trigger transcription.
Here, we show the effects of tuning hrpR’s ability to trigger transcription. C. Examples of how
decreasing off-rate of RNAP to the pHrpL:hrpRaffects the output. We see significant loss of
reliance on the second activator, hrpS, when hrpR is allowed to form an active transcription
complex that unbinds less frequently. Note, this result is symmetric. If we model hrpS, the
AND gate functionality changes in ways consistent to those shown here.
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case, we allow a single activator-DNA-RNA polymerase complex to activate transcription at a decreased
rate relative to the two activator complex. In Figure 5-C, we simulate this effect by varying the unbinding
rate of RNAP to the pHrpL:hrpR complex by more than 100-fold. We begin with a very low unbinding
rate, signifying that RNAP is able to transcribe the single activator complex, pHrpL:hrpR, more readily.
Indeed, we see that even small amounts of hrpR are now sufficient to activate the AND gate. The circuit
still activates readily at high hrpS, since the khrpR:hrpSu < khrpRu , conferring a preference for the double
activator case. Increasing the khrpRu 100-fold in Figure 5-C results in AND gate functionality. This implies
that the AND gate’s functionality depends on the RNA polymerase’s binding specificity to the combinatorial
promoter when both activating signals are present. The experimental result for this AND gate implemented
in Nissle, as shown in Figure 4, displays similar performance as in the model simulations in the last panel
of Figure 5-C. Hence, we can hypothesize about this unknown mechanism of RNAP binding and conclude
that it is indeed a specific binding that occurs primarily when both activators are present.
To further analyze the system behavior we expanded the coarse-grained model of the AND gate to
include the expression of the two activators, hrpR and hrpS as well. We established earlier that the promoter
can initiate transcription when both activators are bound, but also at a slower rate if one or neither activator
binds. The detailed model consisting of all the transcription and translation reactions of this construct also
confirms this. In addition, using the detailed model, we can simulate and understand the dynamics of the
activator transcript and protein levels as well as the dynamics of the reporter transcript and its expression
level. We developed this detailed model using BioCRNpyler [24] and for all model simulations, we used
parameters and initial conditions consistent with those found in the E. coli literature [30].
Figure 6: Full AND Gate Model. A. We model expression of the two split activator
components. This detailed model allows us to tune various parameters to better understand
dynamics. B. In the simulated heatmap, we see leak along the IPTG axis, telling us there is
some underlying activation of pLac even when IPTG concentrations are below the activation
threshold. C. When we input 0 mM IPTG and 1 mM tetrathionate, we see that there is still a
burst of active pLac in the beginning of the time course. This burst of hrpS expression led to
increasing amounts of GFP throughout the simulation. D. This led us to spike in 1 mM lacI
at the beginning of the experiment, preventing the initial spike of unrepressed pLac.
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Effects of repressor initial conditions
To study the effect of initial conditions for the LacI repressor, we use the LacI repression mechanism
that we modeled in our full system description. Two LacI molecules bind to DNA forming a repressed
complex that can not be transcribed. A single IPTG molecule can sequester LacI in solution, preventing the
repressor complex from binding to DNA. IPTG can also bind to the LacI complex bound to DNA, releasing
LacI from the operator region. The AND gate activator hrpR is under the expression of the pLac promoter.
The circuit schematic corresponding to the model is shown in Figure 6-A. Note that when LacI is not bound
to pLac, hrpR is expressed constitutively. We explore the model simulations by plotting the steady state
GFP values under different input conditions as shown in the heatmaps in Figure 6-BD.
A key design aspect that results from this analysis is that if we start with no LacI present, we obtain leaky
activation of the AND gate independent of the IPTG levels as shown in Figure 6-B. This is counterintuitive
since LacI is constitutively expressed in the system. A possible hypothesis could be that the delay in
transcription of LacI leaves enough time for hrpR expression, even at low levels, hence giving a leaky reporter
expression. By looking at the time-course dynamics of the system carefully, we find that this is indeed the
case. We observe that there is a sharp spike in actively transcribing pLac. This causes small amounts of
hrpR transcription, which is enough to activate the AND gate. It is important to note that increasing the
rate of LacI transcription/translation and decreasing the rate of pLac transcription does not fix this issue.
However, we know that the engineered microbe is such that it will always have cellular LacI diluted in from
its parent. So, the case study with zero initial condition for LacI is not applicable in practice. To account
for this in our model, we simply spiked low concentrations of LacI as an initial condition, thus resulting in
recapitulation of the expected AND gate dynamics as shown in Figure 6-D.
3 Methods
3.1 Plasmid construction and strains
Plasmid maps and screening methods are provided in Supplementary Figure 8. All constructs were
assembled using 3G assembly, as described [27]. Constructs were sequence verified by sequencing (Laragen)
after amplification with UNS primers. The sequence for ttrS was identified from Addgene PKD227. We
obtained sequences for ttrR, and pTTR sequences from Addgene plasmids pKD233.7-3. gBlocks with these
sequences were ordered from Twist Biosciences and resuspended in IDTE buffer. Logic gate parts were gifts
from Martin Buck & Baojun Wan. hrpS was amplified from pBW213 (Addgene 61435) hrpR was amplified
from pBW115 (Addgene 61434), pHrpL was amplified from pBW412hrpL-cIgfp (Addgene 61438). The BSAI
cut site was removed from hrpS by Gibson assembly. B0030 and RBSH sequences were obtained from [19]
and synthesized by IDT.
Tetrathionate regulator optimization circuits were transformed into chemically competent JM109 (Zymo
Research). Optimization of AND gate constructs was performed by making constructs with ribosome binding
site library (5’-GAAAGANNNGANNNACTA-3’) in front of regulators in chemically competent Marionette
Clo cells prepared from Addgene [29]. Plasmids were miniprepped and re-transformed into electrocompetent
Nissle 1917 (Mutaflor). Antibiotic concentrations used in all growth was 34 µg/mL chloramphenicol and 50
µg/mL kanamycin.
3.2 In vitro aerobic experiments
Colonies were screened using stereoscope images of LB agar inducer plates with 1 mM potassium
tetrathionate (Sigma Aldrich), 1 mM Isopropyl-beta-D-thiogalactoside (Sigma Aldrich), or both. Successful
colonies that were only fluorescent in the presence of both inducers were then used for in vitro screening.
These colonies were grown overnight in M9CA media (Teknova) to saturation. Cultures were then
diluted 1:5 and grown for three hours. Characterization was performed in 96 well Matriplates (Dot Scientific,
MGB096-1-1-LG-L). Where applicable, inducer media was prepared in M9CA and used to dilute outgrown
cells. Plates were incubated at 37°C for 23 hours in a Biotek Synergy H2 plate reader with continuous shaking
at 282 cpm. Optical densities (OD700) and fluorescence measurements were taken every 5 minutes from the
bottom of the plate. GFP excitation and emission wavelengths were 483 nm and 510 nm, respectively.
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mScarlet excitation and emission wavelengths were 565 nm and 595 nm, respectively. Gain 100 was used for
both fluorescence channels.
4 Discussion
This work demonstrates the engineering and modeling of a two-input AND gate for downstream ther-
apeutic applications, where one input is the medically relevant inflammation signal tetrathionate. We op-
timized our circuit in E. coli Nissle, an attractive microbe for microbiome engineering projects due to its
safety within the human and murine gut [31]. We modeled how our circuit would behave with different
parameter values, informing our choices of engineered elements within the circuit. We varied ribosome bind-
ing sites experimentally, showing that the tetrathionate two-component system’s stronger response could be
recapitulated by varying ribosome binding rates in our model.
Computationally, we designed chemical reaction networks that model our microbial-based circuits in
silico. We screened a wide variety of parameters, drawing from previously published datasets. In our sensing
system modeling, we found that varying ribosome binding rates to regulator transcripts varies the tetrathion-
ate response. Experimentally, we optimized the sensitivity of the two-component tetrathionate inflammation
system in E. coli Nissle. We screened a library containing various RBS strengths and quantified the cir-
cuit’s sensitivity as a function of fluorescent readout. The engineered strain LM19 demonstrated the largest
dynamic range across therapeutically relevant concentrations of tetrathionate. We found experimentally
varying RBS strength results in different fold changes consistent with our model.
We incorporated sensor logic by placing inputs of the split activator AND gate under the regulation of
the tetrathionate and IPTG response promoters. After experimental tuning to minimize leak, this construct
is activated when both tetrathionate and IPTG are present. By creating a chemical reaction network model
of our full AND gate, we were able to identify potential causes for leak in our system. Experimentally,
these cases may offer interesting pathways for studying protein-based logic gates. As we engineer additional
functionality to this circuit, we hope that our in silico RBS tuning and insight into leak will offer us more
understanding of our in vitro results.
In summary, our results demonstrate the usefulness of modular synthetic biological parts and circuit
components to design circuits in microbial chassis capable of logically combining two independent input
signals, one of which is associated with medical applications. We find that logic gates previously described
by Wang et al. can be optimized in E. coli Nissle, allowing for future directions in OR, NOT, NOR,
and NAND integration. In future work, we will characterize our circuit’s ability to sense and respond to
medically-induced inflammation and input signal IPTG in vivo. The engineered circuit’s functional stability
moving from a controlled, in vitro environment to the gut microbiome’s competitive environment presents a
significant challenge from the competition and metabolic burden perspective. As a continuation, we aim to
engineer the second input increase spatial targeting within the gut.
Engineered microbes can deliver effective therapeutics with exquisite spatial and temporal resolution in
medically relevant inflammatory conditions. Synthetic biology may offer advantages over traditional chronic
inflammation therapies by designing targeted drug delivery to tissues affected by disease and rather than
risk off-target effects. The models and logic optimization reported here are a preliminary step towards this
long term goal.
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Supplementary Information
In this section, we describe the two-component system model in detail. The notation x : y denotes a
complex between the chemical species x and y. Moreover, all binding rates are denoted with a “b” superscript,
and unbinding reactions are denoted with a “u” superscript. A superscript P denotes phosphorylated species
and an asterisk superscript is used to denote activated form of a species. The model description is given in
Table 1 and the parameter values can be found in Table 2. All code to regenerate the simulations is publicly
available on Github [26].
Table 1: The Two-Component System Model
Description Reaction
Transcription and Translation of Regulators
RNA Polymerase binds to P1d P + P1d
kb1


ku1
P1d:P
Transcription of ttrS, ttrR P1d:P ktx−−→ ttrST + ttrRT + P1d + P
Translation ttrST to ttrS ttrST + R
kb2


ku2
ttrST:R
ktl−−→ ttrST + R + ttrS
Translation ttrRT to ttrR ttrRT + R
kb3


ku3
ttrRT:R
ktl−−→ ttrRT + R + ttrR
Tetrathionate Regulator Phosphorylation Pathway
Tetrathionate (tt) triggering ttrS phosphorylation ttrS + tt
kb4


ku4
ttrSP + tt
ttrR binding to unphosphorylated ttrS ttrR + ttrS
kb5


ku5
ttrR:ttrS
ttrR binding to phosphorylated ttrS ttrR + ttrSP
kb6


ku6
ttrR:ttrSP
Phosphorylation of ttrR ttrR:ttrSP
kb7


ku7
ttrRP + ttrS
Dephosphorylation of ttrR ttrRP
kdephos−−−−−→ ttrR
Response Regulator Gene Activation
Dimerization of ttrRP ttrRP + ttrRP
kb8


ku8
ttrRP2
ttrRPdimer binding to pTtr promoter ttrRP + pTtr
kb9


ku9
pTtr∗
RNA Polymerase binds to pTtr∗ P + pTtr∗
kb10


ku10
pTtr∗:P
GFP Transcription pTtr∗:P ktx−−→ pTtr∗ + P + GFPT
GFP Translation GFPT + R
kb11


ku11
GFPT:R
ktl−−→ GFPT + R + GFP
Degradation Reactions
ttrST and ttrS degradation ttrST
δ−→ ∅ ttrS δ−→ ∅
ttrRT and ttrR degradation ttrRT
δ−→ ∅ ttrR δ−→ ∅
GFPT and GFP degradation GFPT
δ−→ ∅ GFP δ−→ ∅
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Table 2: Model parameters
S.no. Parameters Description Guess Reference
1 ktx Transcription rate 0.1 transcripts/second Guess
2 ktl Translation rate 1 Guess
3 kdephos Dephosphorylation rate 50 [32]
4 kb1 Binding of RNA polymerase to P1d 10 [33]
5 ku1 Unbinding of RNA polymerase
and P1d complex 0.0001 [33]
6 kb2 Binding of ttrS transcript to its ribosome 0.3 [32]
7 ku2 Unbinding of ttrS and ribosome complex Varies Guess
8 kb3 Binding of ttrR transcript to its ribosome 0.3 [32]
9 ku3 Unbinding of ttrR and ribosome complex Varies Guess
10 kb4 Binding of tetrathionate to ttrS 1.6 [32]
11 ku4 Unbinding of tetrathionate and ttrS complex 0.016 [32]
12 kb5 Binding of ttrR to ttrS 0.0001 [32]
13 ku5 Unbinding of ttrR and ttrS complex 6 Guess
14 kb6 Binding of ttrR to phosphorylated ttrS 0.0001 [32]
15 ku6 Unbinding of ttrR and ttrSP complex 1 Guess
16 kb7 Forward rate for phosphorylation of ttrR 1 [32]
17 ku7 Reverse rate for phosphorylation of ttrR 1 [32]
18 kb8 Dimerization rate of phosphorylated ttrR 0.0083 [32]
19 ku8 Unbinding of the dimerized complex
of phosphorylated ttrR 0.5 [32]
20 kb9 Forward rate of activation of pTtr promoter 0.3 [32]
21 ku9 Reverse rate of activation of pTtr promoter 0.0001 Guess
22 kb10 Binding of RNA polymerase to
activated pTtr promoter 10 [33]
23 ku10 Unbinding of RNA polymerase and
activated pTtr promoter complex 0.0001 [33]
24 kb11 Binding of GFP transcript to its ribosome 100 Guess
25 ku11 Unbinding of GFP transcript
and ribosome complex 10 Guess
Sensitivity Analysis of Two-Component System Model
We performed sensitivity analysis of the two-component system model that describes the tetrathionate
sensor circuit. We looked at the sensitivity of the output GFP fluorescence to changes in reaction rate
parameters. We used COPASI [34], an analysis software for biological models, to compute the normalized
sensitivity coefficients of GFP with different parameter values. A sensitivity coefficient is given as the partial
derivative of the output for each parameter,
S =
∂[GFP]
∂θ
, (1)
where θ is any model parameter. The COPASI sensitivity analysis tools compute this by using the finite
difference numerical approximation. We plot the sensitivity analysis results at the end of the time-course to
show the effects of each parameter on the steady-state reporter protein level.
From the results shown in Figure 7, we can see that some of the sensitive parameters are the ribosome-
binding and unbinding parameters. Although there are other sensitive parameters in the model, they are
not all tunable. This simple model-based analysis confirms our hypothesis and results presented in Figure 2,
where we tuned the ribosome binding strength to optimize the two-component sensor performance.
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Figure 7: Sensitivity analysis of tetrathionate sensor model. Heatmap denoting the
sensitivity of three key species in the tetrathionate sensor model with respect to model param-
eters. The tunable parameters in the experiment are the ribosome binding strengths that are
denoted in the figure.
AND gate constructs
The detailed AND gate constructs are described in Figure 8. Sequences are available as GenBank files
on Github [26]. Circuit diagram plots were created with DNAplotlib [35].
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Figure 8: Constructs and Screening Stages. The tetrathionate construct was optimized
using plate reader screening, while the AND gates were first screened on inducer plates. Stereo-
scope images were taken, and colonies that were OFF in all cases except both inducers were then
chosen for further plate reader assays. Note in the full AND gate, mScarlet is constitutively
expressed, such that the one or no inducer plates are still red fluorescent.
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